Geode Capital Management’s TriSalus Life Sciences TLSI Stock Holding History
Bought
Maintained
Sold
Other funds holding TLSI
FLAM
AIC
NCM
WA
VCM
GGHC
TSW
KCM
Geode Capital Management's TLSI Position: Q1 2026 in Review
Geode Capital Management increased its TriSalus Life Sciences (TLSI) stake by 3.4% in Q1 2026, buying an estimated $127K and bringing the position to 777,094 shares worth $3.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2955.
Geode Capital Management first reported a position in TLSI in Q1 2021 and has held it in 21 quarters since. The position peaked at $5.25M in Q4 2025. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.
- Geode Capital Management held 777,094 shares of TriSalus Life Sciences worth $3.11M as of Q1 2026.
- Geode Capital Management bought 25,887 TriSalus Life Sciences shares in Q1 2026, an estimated $127K.
- TriSalus Life Sciences made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2955 holding.
- Geode Capital Management first reported a position in TriSalus Life Sciences in Q1 2021 and has held it in 21 quarters since.
- Geode Capital Management's TriSalus Life Sciences position peaked at $5.25M in Q4 2025.
- 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.